{"created":"2014-10-06T20:49:03+00:00","modified":"2014-10-30T21:44:18+00:00","valid":{"from":"2014-10-30T21:44:18+00:00","to":"3014-10-30T21:44:18+00:00"},"hreflang":"en","title":"Dallas Ebola Patient Receives Experimental Drug","published":"2014-10-06T22:30:00+00:00","teaser":"Brincidofovir has only been tested against Ebola in the lab and has not yet been tested in animals. The U.S. Food and Drug Administration approved its experimental use on an emergency basis.","itags":["npr_api","354124327"],"guid":"b6fabf68-f429-4aa5-ad1d-ee070140a2f9","contentencoded":"<p><div class=\"fullattribution\">Copyright 2014 NPR. To see more, visit <a href=\"http://www.npr.org/\">http://www.npr.org/</a>.<img src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Dallas+Ebola+Patient+Receives+Experimental+Drug&utme=8(APIKey)9(MDAyOTcwNDAwMDEyODgyMDkwMTgwNzY3YQ001)\"/></div></p>","byline":"Richard Harris","audio":[{"meta":{"duration":"207"},"type":"audio/m3u","href":"http://api.npr.org/m3u/1354124452-dac848.m3u?orgId=1&topicId=1031&ft=3&f=354124327"}]}